Skip to main content
. 2015 May 6;47(1):71–80. doi: 10.3892/ijo.2015.2989

Figure 1.

Figure 1

Combined treatment with PD0325901 and rapamycin has a synergic effect on (A) angiosarcoma and (B) melanoma viability. Average cell viability (%) and corresponding CI (color code) for PD0325901 in combination with rapamycin. The values shown are for three replicates of three parallel experiments in which cells were treated for 72 h.